Bilirubin Increases the Risk of Nosocomial Infection in Cirrhotic Patients
{bilirubin}
Jaundice Predisposes to the Incidence of Nosocomial Infection in Egyptian Patients With Cirrhosis: A Cohort Study
1 other identifier
observational
250
1 country
1
Brief Summary
Nosocomial infection (NIs) is a major challenge in healthcare facilities and has been associated with prolonged hospital stay as well as increased morbidity and mortality. This research aimed to estimate the impact of acute decompensation (AD) consequences on the successive risk of nosocomial infections (NIs) and the go after outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 21, 2023
CompletedFirst Posted
Study publicly available on registry
March 2, 2023
CompletedMarch 6, 2023
February 1, 2023
10 months
February 21, 2023
March 2, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
occurrence of nosocomial infection
1 months
Study Arms (2)
group 1
the group that develops Nis during the study
group 2
the group doesn't develop NIs
Eligibility Criteria
patients were diagnosed with cirrhosis based on liver biopsy. Decompensation was defined as acute deterioration in liver function accompanied with acute onset of complications such as ascites, HE, GIH, BIs, or jaundice at the time of hospitalization
You may qualify if:
- cirrhotic patients both sex
You may not qualify if:
- pregnancy
- lactation
- HCC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Tanta University
Tanta, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant lecturer
Study Record Dates
First Submitted
February 21, 2023
First Posted
March 2, 2023
Study Start
January 1, 2022
Primary Completion
November 1, 2022
Study Completion
November 1, 2022
Last Updated
March 6, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share